Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

China · Delayed Price · Currency is CNY

21.25

+0.32 (1.53%)

Jun 18, 2026, 3:04 PM CST

3.11% (1Y)

Market Cap	10.96B +2.8%
Revenue (ttm)	1.09B +15.9%
Net Income	425.83M +35.2%
EPS	0.81 +35.2%
Shares Out	523.58M
PE Ratio	25.73
Forward PE	24.20
Dividend	0.25 (1.20%)
Ex-Dividend Date	Jan 20, 2026

Volume	5,937,569
Open	21.48
Previous Close	20.93
Day's Range	20.65 - 21.57
52-Week Range	19.77 - 35.84
Beta	0.39
Analysts	Buy
Price Target	38.26 (+80.05%)
Earnings Date	Aug 21, 2026

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of diagnostic and therapeutic products for allergic diseases in China and internationally. The company offers Changdi, a skin prick test product and dust mite drops; Changhao, an Artemisia annua pollen allergen sublingual drop; and Changdian, a dust mite skin prick test diagnostic kit. It is also involved in the research and development of cells and natural medicines. The company was founded in 2002 and is headquartered in Huzhou, China. [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 2002

Employees 1,808

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300357

Full Company Profile

Financial Performance

In 2025, SHE:300357's revenue was 1.06 billion, an increase of 14.81% compared to the previous year's 925.39 million. Earnings were 380.94 million, an increase of 19.86%.

Financial Statements